ClinicalTrials.Veeva

Menu

Revitalization of Damaged Skin Due to Chronic Skin Diseases

A

ACE Cells Lab

Status and phase

Unknown
Early Phase 1

Conditions

Atopic Dermatitis
Psoriasis
Chronic Eczema

Treatments

Combination Product: ACE CSD

Study type

Interventional

Funder types

Industry

Identifiers

Details and patient eligibility

About

Chronic skin disease lead to skin damage and disfiguring to the patient skin. Sometimes, achieving normal skin is not possible by the normal traditional treatment, this study is focusing on use of ACE CSD formula which is mixture of natural peptides and herbs. the main aim is to restore the normal skin appearance for the patient and control the episodes of flare.

Full description

Psoriasis is a chronic, immune mediated (type 2 and type 17) chronic skin disease. The production of the immune proteins that leads to continuous inflammatory mediated process. The result of chronic inflammation is they hyper keratotic layer of skin which gets attacks of atopic dermatitis leading to symptoms of itching, pruritis and in situ bleeding.

ACE CSD, with the multiple factors that mediates the immune response and control the protein receptors, in addition to the multiple regeneration peptides that are specifically extracted from healthy skin of newly born sheep; in addition to multiple Chinese herbs that contains different anabolic factors was tested to be able to regenerate the damaged skin and locally modulate the immunity reactions so the skin can regenerate fully to replace the damaged skin with normal healthy skin.

Enrollment

200 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Chronic skin condition lasts for more than 1 year.
  • tried traditional treatment with limited or without effect.
  • not on steroids for at least 6 weeks.

Exclusion criteria

  • patients on steroid.
  • patients intolerable to protein or allergic to proteins
  • during pregnancy or lactation

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

200 participants in 1 patient group

internvention of Chrinic skin conditions
Experimental group
Description:
All cases of chronic skin conditions will be included to measure the effect on the 3 of them and whihc one will respond to the treatment better
Treatment:
Combination Product: ACE CSD

Trial contacts and locations

2

Loading...

Central trial contact

Dr. Diana Diana, MsC Dermatology; Dr. Alaa Abdelkarim MF Mohammed

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems